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Since the ﬁrst identiﬁcation of the virus in 1971, the disease caused by canine coronavirus (CCoV) has not been adequately
investigated, and the role that the virus plays in canine enteric illness has not been well established. Only after the emergence
in 2002 of SARS in human has new attention been focused on coronaviruses. As a consequence of the relatively high mutation
frequency of RNA-positive stranded viruses, CCoV has evolved and, with the biomolecular techniques developed over the last two
decades, new virus strains, serotypes, and subtypes have been identiﬁed in infected dogs. Considering the widespread nature of
CCoV infections among dog populations, several studies have been carried out, focusing upon the epidemiological relevance of
these viruses and underlining the need for further investigation into the biology of CCoVs and into the pathogenetic role of the
infections. This paper reports the evolutionary processes of CCoVs with a note onto recent diagnostic methods.
1. Coronaviruses:Genome andStructure
Coronaviruses (CoVs), a genus in the Coronaviridae family,
order Nidovirales, are large, enveloped, RNA viruses that
cause highly prevalent diseases in humans and domestic
animals. CoVs are spherical enveloped particles about 100–
120nm in diameter with a capped, polyadenylated single-
stranded, positive-sense genomic RNA 27.6 to 31kb in
length, the largest known RNA virus genome. The 5 end
of the genome consists of a 65 to 98nt sequence, termed
the leader RNA, that is also present at the 5 end of all
subgenomic mRNAs. An untranslated region (UTR) of 200
to 400nts follows this leader sequence. At the 3 end of the
RNA genome is another UTR of 200 to 500nts followed by a
poly(A) sequence of variable length. Both 5-a n d3 -UTRs
are important for RNA replication and transcription. The
remaining genomic sequence includes diﬀerent open reading
frames (ORFs) which diﬀer markedly among coronaviruses
in number, nt sequence, genes order, and in method of
expression. At the 5 end of each gene, all CoVs have a
common intergenic sequence of about 7 bases which is
essential for the formation of subgenomic RNAs [1].
The ﬁrst two-thirds of the genome consists of two
partially overlapping ORFs, ORF1a and ORF1b. These ORFs
are translated into a polyprotein which is the precursor
both of the viral RNA-dependent RNA polymerase and
of proteases. The one-third in the 3 end of the genome
contains ORFs encoding for the major structural proteins,
spike (S), envelope (E), membrane (M), and nucleocapsid
(N) proteins. These ORFs are interspersed with several ORFs
encoding for diﬀerent nonstructural proteins, most of which
are of unknown function (Figure 1).
The S glycoprotein, which forms the large spikes on the
surface, is the major inducer of virus-neutralizing antibodies
and plays an important role in the biology and pathogenesis
of CCoV infections, inducing both fusion of the viral
envelope with host cell membranes and cell-to-cell fusion.
In most phylogroup 2 CoVs (Betacoronavirus, see below),
the 180kDa S protein is cleaved during or after virus
maturation by a cellular protease enhancing the cell fusion
activity or viral infectivity. The S protein of phylogroup
1C o V s( Alphacoronavirus, see below) is not cleaved even
though some of these viruses can induce cell-to-cell fusion
[2]. The small envelope protein E, which is 9–12kDa, was
recently shown to be associated with the viral envelope, and
together with the M protein, is required for viral budding
[3]. The M membrane protein, a type III glycoprotein, is
characteristic in that only a short amino-terminal domain is
exposed on the surface of the viral envelope. This domain
is followed by a triple-membrane-spanning domain and2 Advances in Virology
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Figure 1: Genetic structure of CCoV type 2 (a) and CCoV type 1 (b). The numbers above the bars indicate ORFs. The names in the bars
indicate the protein encoded by the corresponding ORF. The structural proteins are marked by various letters, while the nonstructural
proteins are represented by unﬁlled boxes. The arrow (b) indicates the accessory gene, ORF 3, unique to CCoV type 1.
a large carboxyl-terminal domain inside the envelope [4].
Although the major immunological role has been attributed
to the S protein, antibodies to the M protein of MHV
can neutralize viral infectivity but only in the presence of
complement [5]. The nucleocapsid protein N is a basic
phosphoprotein of 50–60kDa that binds to virion RNA,
providing the structural basis for the helical nucleocapsid
[6].NplaysaroleinviralRNAsynthesisandinteractswithM
proteinleadingtotheformationofvirusparticles.Additional
ORFs encoding nonstructural proteins have been recognized
in CoV genomes [7, 8]. The functions of such genes are in
most cases unknown and most of them are not essential for
virus replication, but may play a part in virulence and host
range [9].
Presently, the Coronaviridae family is bigeneric and
comprises the genera Coronavirus and Torovirus. In rooted
trees, the members of the genus coronavirus consistently
form three distinct monophyletic groups, and in pairwise
comparisonstheyformthreerobustnonoverlappingclusters.
This phylogenetic constellation is well recognized, and in
publications these three groups are consistently referred to
as phylogroups 1, 2, and 3. Phylogroup 1 of the CoVs
includes human coronaviruses HCoV-229E and HCoV-
NL63, feline coronaviruses (FCoVs) type 1 and type 2,
transmissible gastroenteritis virus (TGEV) of swine, porcine
respiratorycoronavirus(PRCoV),porcineepidemicdiarrhea
virus (PEDV) and canine coronaviruses (CCoVs). Recently,
a ferret coronavirus has been identiﬁed as a member
of phylogroup 1 [10]. Phylogroup 2 of the mammalian
CoVs is split into two subgroups, bovine-like subgroup
2a and SARS-like subgroup 2b. Subgroup 2a includes
bovine coronavirus (BCoV), murine hepatitis virus (MHV),
sialodacryoadenitis virus (SDAV) found in rats, porcine
haemagglutinating encephalomyelitis virus (PHEV), human
coronaviruses (HCoV-OC43 and HCoV-HKU1), human
enteric coronavirus (HECV-4408), and the newly recognized
equine coronavirus (ECoV) [11] and canine respiratory
coronavirus (CRCoV) [12]. Soon after its discovery, SARS-
C o Vw a se x p e c t e dt od e ﬁ n ean e w4 t hg r o u p[ 13]. However,
based on sequence comparisons and the observation that
regions of ORF1a of SARS-CoV contain domains that
are unique to the group 2 coronaviruses, it has been
suggested that it is more directly related to phylogroup
2. Thus, SARS-CoV has been placed within subgroup 2b
together with SARS-like CoVs isolated from bats and wild
carnivores [14, 15]. A third phylogroup includes the two
avian coronaviruses, infectious bronchitis virus (IBV), and
turkey coronavirus (TCoV).
However, in view of the recent increase in the number
of newly discovered coronaviruses and ensuing debates and
confusion in the literature concerning coronavirus taxon-
omy, the members of the coronaviridae study group (CSG)
have developed a framework for consistent classiﬁcation and
have established deﬁnite genus- and species-demarcation
criteria. The intergroup pairwise amino acid identity scores
for the true coronaviruses are comparable to those calculated
for structural and nonstructural proteins of diﬀerent genera
inotherRNAvirusfamilies(e.g.,Potyviridae,Picornaviridae)
[16]. The proposed taxonomic revision to the ICTV Exec-
utive Committee of the Coronaviridae and the organization
of the still-to-be-established subfamily Coronavirinae are
based upon rooted phylogeny and pairwise comparisons
using Coronaviridae-wide conserved domains in replicase
polyprotein (ORF1ab), as well as the structural proteins S,
E, M, and N [16–18]. Based on this de facto criterion, the
CSG has formulated a taxonomic proposal to the ICTV
Executive Committee, which would intuitively follow the
unoﬃcial (but widely accepted) nomenclature, to convert
phylogroups 1 through 3 into genera designated Alpha-,
Beta- and Gammacoronavirus,r e s p e c t i v e l y ,( Figure 2). The
viruses grouped in currently recognized genera form distinct
monophylogenetic clusters, but do not share other obvious
traits (host tropism, organ tropism, and type of disease), to
suggest a common denominator.
2. CanineEntericCoronaviruses:
Evolutionary Changes
CCoV was ﬁrst described during an epizootic in a canine
military unit in Germany in 1971 [19]. Starting from this
ﬁrst report, CCoV was isolated repeatedly from aﬀected dogs
and today appears to be enzootic worldwide, and dogs of all
breeds and ages seem to be susceptible to infection [20–26].
Whereas fatal infections are unusual unless mixed with
infections by other pathogens or with overcrowding and
unsanitary conditions, CCoV alone is an important canine
pathogen responsible for epizootics [27]. Nevertheless, theAdvances in Virology 3
Order
Genus
Family
Nidovirales
Coronaviridae
Torovirus
Arteriviridae Roniviridae
Arterivirus Coronavirus Okavirus
(a)
Subfamily
Order
Genus
Family
Nidovirales
Coronaviridae
Alpha-
coronavirus
Beta-
coronavirus
Gamma-
coronavirus
Torovirus Baﬁnivirus
Torovirinae Coronavirinae
(b)
Figure 2: Current taxonomic organization of the Nidovirales and of the Coronaviridae family (a) and envisaged revision proposed to the
ICTV Executive Committee (b).
disease caused by CCoV has not been adequately inves-
tigated, and the role it plays in canine enteric illness is
not established in detail. Since its ﬁrst isolation in 1971,
CCoV has evolved, and in the last two decades researchers
have focused on the genomic variability of CCoV strains,
identifying new genotypes/types.
In 2001, by sequence analysis of CCoVs detected in
fecal samples collected from diarrheic dogs in the South of
Italy, multiple nt substitutions accumulating over a fragment
of the M gene were observed [28]. The point mutations
aﬀecting the M gene were later observed in the sequences
of CCoVs detected in the faeces of two naturally infected
pups during the latter stages of long-term viral shedding.
These CCoVs are dissimilar from the 1971-like CCoVs,
showing an evident genetic drift toward FCoVs type 2, and
it was postulated that the two dogs might have been infected
by a mixed population of genetically diﬀerent CCoVs, or
that the viruses detected in both pups were the result of
mutation/recombination events [29].
These preliminary observations gave a meaningful
impulse to studying the genetic evolution of CCoVs. Exten-
sive sequence analysis on multiple regions (ORF1a, ORF1b,
and in particular ORF5) of the viral genome from CCoV-
positive faecal samples, provided strong evidence for the
existence of two separate genetic clusters of CCoV. The
ﬁrst cluster includes CCoVs intermingled with reference
CCoV strains, such as Insavc-1 and K378, while the second
cluster segregates separately from CCoVs and, presumably,
represents a genetic outlier referred to as FCoV-like CCoVs
[30]. A possible explanation for this diﬀerent segregation is
that under natural conditions homologous recombination
events between highly homologous CoVs, such as CCoV
and FCoV, occur frequently. Where the recombination takes
place is unknown, but it is known that CCoV is able to use
the feline aminopeptidase (fAPN) glycoprotein as a cellular
receptor [31] and that, under experimental conditions, cats
can be infected with CCoVs [32]. This means that a frequent
interspecies circulation either of FCoVs to dogs or of CCoVs
to cats may occur, since mixed infections are required to give
rise to recombination events. Another supposition is that
recombination events have developed in a host other than
cat or dog, such as a wild carnivore, or that a wild carnivore
might have harbored the immediate ancestor of CCoV.
The analysis of CoV RNAs from various wild carnivore
isolates could shed light on these hypotheses. According to
these speculations, restricted sites of recombination, such as
regions of very high nt identity between highly homologous
CoVs, may exist in the genome of CoVs. This explanation
assumes that CoVs in carnivores possess a sort of “dynamic”
genome [30].
Taking into account the genetic drift toward FCoV
observed in the M gene of the FCoV-like CCoVs, the
genetic diﬀerences between these divergent strains and the
typical reference CCoV strains were evaluated in the ORF2
sequence, characterized by a more evident variability. The nt
sequence of a region encompassing about 80% of the S gene4 Advances in Virology
of one of these FCoV-like CCoVs, strain Elmo/02, clearly
indicates that a novel CCoV type, highly divergent from the
reference CCoV strains and more closely related to FCoV
type 1, circulates among dogs. Comparison of the inferred
amino acid sequences revealed about 81% identity to FCoVs
type 1 and about 54% identity to both FCoVs type 2 and
CCoV reference strains. On the basis of the evident and
signiﬁcantidentitiesbetweenElmo/02strainandFCoVstype
1, the new strain Elmo/02 was designated as the prototype
of the newly recognised genotype 1 (CCoV type 1), and
the reference strains were designated as CCoV type 2 [33].
The high divergence in the amino acid composition and
the loss and gain of potential glycosylation sites compared
to the most closely related coronaviruses (FCoV type 1,
FCoV type 2, and typical CCoV), strongly suggest that the
Elmo/02 strain is antigenically poorly correlated to the other
coronaviruses of carnivores. Figure 3 reports the phyloge-
netic relationship of the S gene from diﬀerent human and
animalCoVs.Phylogeneticanalysisclearlydemonstratesthat
CCoV type 1, strain Elmo/02, segregates with FCoVs type 1
rather than reference CCoV type 2 strains and FCoV type 2
strains.Moreover,thepresenceofthestretchofbasicresidues
RRXRR is indicative of a potential cleavage of the S protein.
A similar basic motif is present, approximately in the same
position, in all betacoronaviruses and gammacoronaviruses
identiﬁed and classiﬁed to date. Recently, Lorusso et al.
[34] also has described an accessory gene, ORF3, 624nts
in length, unique to CCoV type 1 (Figure 1). The putative
encoded protein, with a predicted molecular weight of about
24kDaa, is 207 amino acids long, and the observation that
notransmembraneregionhasbeendetectedsuggeststhatthe
protein is secreted from the infected cells.
The signiﬁcance of all these data is still unclear, but it
raises several questions regarding the biology of CCoVs. The
literature on CCoVs-induced disease oﬀers little or no useful
information, and although in more recent years additional
important data have shed light on the more obscure aspects
of the infection, several studies need to be performed to
extend knowledge of these two CCoV genotypes. The data
acquired on the genome of the enteric CCoVs and on their
evolution focus upon important epidemiological outcomes
in the ﬁeld, in terms of both prophylaxis and virus evolution.
Hence, the serological correlation between the two viruses
requires further study, and several questions regarding the
pathobiology of CCoV type 1 and the eﬃcacy of currently
available CCoV vaccines that contain only CCoV type 2
remain to be answered.
3. EntericCCoVs: Pathobiology and
Epidemiology
The factors regulating the course of the natural diseases
caused by enteric CCoVs are not well understood. CCoVs
are responsible for enteritis in dogs, and signs of infections
m a yv a ryf r o mm i l dt om o d e r a t e ,b u tt h e ya r em o r es e v e r ei n
young pups or in combination with other pathogens. Com-
mon signs include soft faeces or ﬂuid diarrhoea, vomiting,
dehydration, loss of appetite, and, occasionally, death. Dual
infections by CCoV and canine parvovirus type 2 (CPV2)
are especially severe when infections occur simultaneously
[35], but CCoVs can also enhance the severity of a sequential
CPV2 infection [36].
The natural route of transmission is faecal-oral, and
virus in faeces is the major source of infection. In neonatal
dogs, the virus appears to replicate primarily in the villus
tips of the enterocytes of the small intestine causing a lytic
infection followed by desquamation and shortening of the
villi and resulting in diarrhoea 18–72h post infection [37].
Production of local IgAs restricts the spread of the virus
within the intestine and arrests the progress of the infection.
Therefore, infected dogs may shed virus for as long as 6
months after clinical signs have ceased [29, 38].
Recent extensive biomolecular analysis of faecal samples
collected from infected dogs in Italy revealed that CCoVs
infection is widespread and often characterized by the
occurrence of both genotypes simultaneously [39, 40].
C C o V st y p e1a n dt y p e2w e r ef o u n dt ob ec o m m o ni na n
Australian animal shelter with CCoV type 1 being prevalent
[41]. CCoVs have also been found in Western European dog
populations [42]. They have been detected in all European
countries examined, and, except for the UK, the prevalence
ofCCoVtype1waslowerthanforCCoVtype2[25].Reports
of widespread CCoVs have come from Sweden [21]a n d
China [43]. Soma et al. [24] reported that CCoVs are also
circulating in Japan, and the detection rate for dogs aged
under 1 year was 66.3%, with a simultaneous detection rate
of both types up to 40%.
These data raise several questions, and more indepth
investigations into the pathobiology of CCoVs type 1 and
type 2 are required. Therefore, failure to isolate CCoV type
1 in vitro [40] hinders the acquisition of key information on
the pathogenetic role of CCoV type 1 in dogs and prevents
an authentic evaluation of the immunological characteristics
of this new genotype.
4. Divergence Strains and the Emergence of
the Pantropic CCoV
CCoVs, like other CoVs, show relatively high mutation
frequency, and, in recent decades divergent strains have been
described. One of the ﬁrst observations was from Wesley,
[44] who demonstrated that although most CCoV sequences
are FCoV-like, the N-terminus of the S gene of CCoV strain
UCD-1 is more closely related to TGEV.
The identiﬁcation of a novel CCoV, strain UWSMN-1,
from a fatal case of gastroenteritis in pups from breeding
colonies was reported in Australia in 2001 [23]. Sequence
analysisoffragmentsofthe Sandpolymerase genesconﬁrms
that the Australian isolate is divergent from CCoV and
FCoV classical strains, and in comparing the 751nts in
the 3 region of the S gene, it was found that UWSMN-
1 had 21 unique sites and that there were 112 sites where
the strain was diﬀerent from at least one of the other
strains analyzed. These diﬀerences appear to be randomly
interspersed, demonstrating that the divergent 5 region of
the S gene in UWSMN-1 is probably not the result ofAdvances in Virology 5
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Figure 3: Phylogenetic tree of the spike protein of coronaviruses. CoV strains employed for tree construction are reported (GenBank
accession numbers are reported in parentheses). Alphacoronaviruses: CCoV type 2 Insavc (D13096), CCoV type 2 K378 (X77047), CCoV
type 2 BGF10 (AY342160), CCoV type 2 CB/05 (DQ112226), CCoV type 1 Elmo/02 (AY307020), CCoV type 1 23/03 (AY307021), FCoV
type 2 79-1146 (X06170), FCoV type 2 79-1683 (X80799), FCoV type 1 KU-2 (D32044), FCoV type 1 Black (AB088223), FCoV type
1 UCD1 (AB088222), TGEV Miller (S51223), PRCoV RM4 (Z24675), PEDV CV777 (NC 003436), HCoV-229E (NC 002645), CFBCoV
CFB/GD/DM95/03 (EF192156). Betacoronaviruses: SARS-CoV tor2 (NC 004718), BCoV-Mebus (U00735), CRCoV 4182 (DQ682406),
HCoV OC43 (NC 005147), PHEV VW572 (DQ011855), MHV A59 (AY700211), SDAV 681 (AF207551), ECoV NC99 (NC010327).
Gammacoronaviruses:IBVBeaudette(DQ830981),TCoVG1(AY342357).Phylogenetictreewasgeneratedbytheneighbour-joiningmethod
in the Mega3 program [51], and statistical support was provided by bootstrapping >1,000 replicates. Scale bar indicates amino acid
substitutions per site. Dog CoVs are grey shaded.
recombination events between FoCVs and CCoVs, as would
be indicated if the S gene shared blocks of homology with
either FoCV or CCoV S genes. Rather, UWSMN-1 appears
to be generally divergent due to a gradual accumulation of
mutations throughout its genome, which may be reﬂective
of its isolated evolution in Australia [45].
In 2002, an epizootic outbreak of diarrhea occurred in a
Beagle breeding colony in United Kingdom. A new CCoV,
strain BGF10, was isolated and characterized. The virus
revealed a highly divergent region at the amino-terminal
domainoftheMproteinandalongnonstructuralprotein3b
of 250 amino acids associated with virulence in other CoVs
[46].
In 2005, a fatal disease in puppies was described in Italy,
and a pathogenic variant of CCoV, strain CCoV type 2-
CB/05, was isolated from all tissues examined except brain
[47]. The sequence of the 3 end of the genome of the
pantropic CCoV strain showed a high degree of amino acid
identity with CCoV type 2, except for the S protein that
displayed the highest identity to FCoV type 2, strain 79-16836 Advances in Virology
(Figure 3).ThehighestidentityoftheEproteinwasobtained
against TGEV strain Purdue in whose cluster the virulent
CCoV was found to fall by phylogeny. The N protein too,
which was 383 amino acids long, was found to be closely
related to TGEV strain Purdue by both sequence analysis
and phylogeny. Interestingly, nonstructural protein 3b (22
amino acids) was shorter than expected [48]. In a recent
experimental study, Decaro et al. [49] demonstrated that
strain CCoV type 2-CB/05 is able to infect dogs seropos-
itive to enteric CCoV and is able to induce clinical signs
irrespective of the viral dose administered in the challenged
dogs.Theinfecteddogsshowedlymphopenia,andviralRNA
was detected in thymus, spleen, and lymph nodes of some
infected dogs, demonstrating the lymphotropism of the new
strain CCoV type 2-CB/05. The study also provides evidence
thatimmunityinducedbynaturalexposuretoentericCCoVs
isnotfullyprotectiveagainststrainCCoVtype2-CB/05.This
important datum highlights the fact that dogs vaccinated
with enteric CCoV may acquire subclinical infections with
CCoVtype2-CB/05-likevirus,resultinginlymphopeniaand
predisposing for opportunistic pathogens and/or for a more
severe disease induced by canine parvovirus.
Recently, CCoVs with a potential double recombinant
origin through partial S-gene exchange with TGEV were
identiﬁed in the gastrointestinal tract and internal organs of
pups which had died of acute gastroenteritis [50]. A TGEV-
like CCoV, strain UCD1, has been previously described,
but only partial S-gene sequences were determined, thus
preventing a complete genomic characterization [44]. The
new CCoV strains were strictly related to TGEV in the N-
terminal domain of the spike protein, whereas the rest of the
genome revealed a higher genetic relatedness to CCoV type 2
isolates. The relevant antigenic diﬀerences observed between
reference CCoV type 2 and recombinant TGEV-like CCoVs
could have implications for prophylaxis programs, as dogs
administered classical CCoV vaccines may be susceptible to
infection caused by the recombinant virus.
5. Respiratory Canine Coronavirus
Another example of the evident evolution of dog coron-
aviruses, as a consequence of the accumulation of point
mutations, small insertions, and deletions in coding and
non-coding regions of the genome, is the recent identiﬁca-
tion of a novel coronavirus, canine respiratory coronavirus
CRCoV, in tissue samples collected from the respiratory
tract of diseased dogs. During a survey to establish the
causes of canine infectious respiratory disease in a large
rehoming kennel in the United Kingdom, a CRCoV was
isolated in tracheal and lung samples in dogs with mild
clinical symptoms. The virus showed a close relationship to
the betacoronavirus in the polymerase and S genes, with the
highest amino acid identity with the corresponding BCoV
proteins and proved to be only distantly related to enteric
CCoVs. By sequence comparison of cDNA polymerase in
the analyzed 251bp sequence, the identity was 98.8% for
BCoV and 98.4% for HCoV polymerase gene, whereas it
was only 68.5% for CCoV, strain 1–71. When comparing the
amino acid sequence obtained by translation of the cDNA
sequence from CRCoV to the amino acid sequence of BCoV,
HCoV-OC43, and enteric CCoV spike proteins in an overlap
of 1093 amino acids, the identities were 96%, 95.2%, and
21.2%, respectively (Figure 3). Moreover, the presence of
the HE gene, which is a characteristic protein gene of the
members of the betacoronaviruses, has been demonstrated
in the CRCoV genome [12, 52]. Since its detection in 2003,
CRCoV has been found to be present in dogs in other
European countries, as well as in Canada and in Japan [53–
58]. The evolution of the betacoronaviruses is closely linked,
and it has been suggested that these viruses share a recent
common ancestor. CRCoV may also share this ancestor or
may have originated from a transfer of BCoV to dogs. In
order to conclusively answer the question of whether CRCoV
has only recently emerged, a greater number of archived
materials need to be tested. In addition, more sequence
informationfromCRCoVstrainswillberequiredtoperform
phylogenetic analyses that may shed more light on their
origins.
6.New AdvancesinDiagnosis
The clinical signs most frequently associated with enteric
CCoVs are not easily diﬀerentiated from those associated
with other enteric pathogens such as CPV2 or canine
rotavirus and canine adenovirus. Consequently, CCoV diag-
nosis requires laboratory conﬁrmation. The diagnostic tech-
niques employed for the detection of CCoVs in fecal samples
include electron microscopy (EM), virus isolation (VI) in
cell cultures, and biomolecular analysis. EM examination of
negatively stained fecal suspensions and immune electron
microscopy are rapid procedures for detecting coronavirus
and appear to be valuable diagnostic tools [59]. How-
ever, coronavirus-like particles in intestinal contents often
resemble coronaviruses [60], and EM examination required
specialized laboratories and technicians. VI is the most
commonly used technique for diagnosis of CCoVs infection
[45], but is more complex, more time-consuming and less
sensitive than other methods. CCoV type 2 grows on several
cell lines of canine and feline origin, and the identiﬁcation
of an isolate requires neutralization of the cytopathic eﬀects
and/or immunoﬂuorescence test with a reference serum or
monoclonal antibodies. Failure to isolate CCoV type 1 in
cell cultures [40] reduces the changes of identifying many
forms of enteritis caused by this virus, so the frequency
of CCoV type 1 disease is probably underestimated. Such
diﬃcultiesandlimitationspreventanauthenticevaluationof
the immunological characteristics of this new genotype and
hindertheacquisitionofkeyinformationonitspathogenetic
role in dogs.
In the past decade, several PCR-based methods have
been developed for detecting CCoV RNA in the feces of
dogs, allowing the detection limits of virus isolation to be
overcome. PCR has been identiﬁed as the gold standard
because of the improvement in both sensitivity and speci-
ﬁcity when compared to conventional methods [20, 23, 61,
62]. Therefore, none of the developed PCRs were designedAdvances in Virology 7
to be quantitative. Moreover, conventional PCR contains a
certain risk of carryover contamination due to post-PCR
manipulations and to a second ampliﬁcation step in nested
PCR systems, especially when a high sample throughput is
required. Conversely, real-time TaqMan RT-PCR enables a
sensitive and speciﬁc quantitation of viral RNA [63–66].
Decaroetal.[67]developedareal-timeﬂuorogenicRT-PCR,
a simple, rapid, and reproducible method for the detection
and quantitation of CCoV RNA in the feces of infected
dogs, based on the TaqMan technology. In comparison
to conventional RT-PCR, the ﬂuorogenic assay is a closed
system in which the tube is never opened postampliﬁcation,
ruling out the possibility of cross-contamination. The main
advantage of the ﬂuorogenic dye system consists of quantify-
ing CCoV RNA amounts in fecal samples with a high degree
of reproducibility and precision compared to quantitative
gel-based PCR assays [68, 69].
Recently, two genotype-speciﬁc ﬂuorogenic RT-PCR
assays were developed for the detection, discrimination, and
quantitation of CCoV type 1 and CCoV type 2 RNAs in
the feces of dogs with diarrhea. The assay showed high
speciﬁcity, sensitivity, and reproducibility, allowing a precise
quantitation of CCoVs RNA over a linear range of about
eightordersofmagnitude,from101 to 108 copiesofstandard
RNA. The genotype-speciﬁc ﬂuorogenic assay can be useful
to detect and measure viral loads in fecal samples collected
from dogs naturally or experimentally infected with type 1,
type 2, or both genotypes [39].
7. Conclusion
One of RNA’s most intriguing features is its ability to carry
geneticinformationdespiteitslabilenature.CoVsareunique
among RNA viruses in many aspects of their biology. They
are characterized by a extremely large genome, by a nested
set of subgenomic mRNAs, by a discontinuous transcription
mechanism, and by a high frequency of RNA recombination
events because of the high error frequencies of RNA poly-
merase [70]. Genetic recombination is an important mech-
anism for generating novel genomes that may have selective
advantages over parental genomes. In the evolution of RNA
viruses, RNA recombination is a widespread phenomenon
that has shaped viruses by rearranging viral genomes or
disseminating functional modules among diﬀerent viruses
[71]. Although nonsegmented genomes of RNA viruses
generally exhibit very low or undetectable recombination
frequencies, the recombinations for the entire CoV genome
have been calculated to be as high as 25% [72]. The high
frequency of RNA recombination in CoVs is probably the
result of the unique mechanism of coronavirus synthesis,
which involves discontinuous transcription and polymerase
jumping. It is possible that the viral polymerase associated
with the incomplete nascent RNAs, dissociates from its tem-
plate at a random point, and switches to a homologous site
on a diﬀerent RNA template to complete RNA synthesis by a
copy-choice mechanism [73]. Depending on the precision of
the repair mechanism, the repaired genome may be similar
to the parental genome, or it may contain further mutations.
This illustrates that sequence diversity in RNA sequences
generated by genetic recombination can involve both gross
changesandminormutations.Geneticdivergencewithinthe
alphacoronavirus is accounted for by linear evolution as well
as by sudden dramatic shifts generated by RNA deletions or
recombination [74].
RNA recombination has been developed into a potent
genetic tool to introduce desired RNA sequences into CoV
genomes, revealing itself as an important mechanism in the
natural evolution of CoVs. For example, new strains of IBV
in poultry ﬂocks are the results of natural recombination
between diﬀerent ﬁeld strains. FCoVs type 2 have arisen
by recombination events between FCoV type 1, wholly
feline, and CCoV, resulting in a FCoV genome consisting
of the spike gene and part of the adjacent gene from CCoV
[75]. Recombination may also play a role in the evolution
of diﬀerent coronavirus species and may also explain the
acquisition of the HE gene from an mRNA of inﬂuenza C
virus by a progenitor of the betacoronaviruses [1]. The S
protein of PEDV occupies an intermediate position between
HCoV 229E and TGEV [76], while the S protein of PRCoV
is highly related to TGEV but has a large deletion in the
N-terminus (more than 200 amino acids) that may explain
the change in the pathobiology of the virus [77]. SARS
emerged as a human disease associated with pneumonia
in Guangdong Province, China, in November 2002. The
etiological agent of SARS appears to be an animal virus
that crossed to humans. The existence of a 29-nt deletion
sequence in the genome of a wild mammal CoV conﬁrms
the adaptation of this new virus to humans [78].
As a consequence of the relatively high mutation fre-
quency, the RNA viruses have the potential to rapidly adjust
to certain negative pressures, such as those presented by
the immune system. Recombination events aﬀecting CCoVs
could clarify the evolutionary processes leading to the
proliferation of new virus strains, serotypes, and subtype, as
happened for SARS-CoV and for strain CCoV type 2-CB/05.
Notwithstanding the several studies carried out on CCoVs,
there are a lot of aspects yet to be clariﬁed: the meaning of
simultaneous infection by CCoV type 1 and CCoV type 2,
the real pathogenetic role of these two viruses, the immune
response against CCoV type 1 and CCoV type 2, and the
assessment of CCoV type 2 CB/05-like virus distribution
among dog populations.
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